Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for siRNA targeting HIF-1α for nasopharyngeal carcinoma therapy

References

• ChenYYangLHuangSDelivery system for DNAzymes using arginine-modified hydroxyapatite nanoparticles for therapeutic application in a nasopharyngeal carcinoma modelInt J Nanomedicine201383107311823983464
   PubMed Web of Science ®Google Scholar
• SarmientoMPCBMejiaMBAPreliminary assessment of nasopharyngeal carcinoma incidence in the Philippines: a second look at published data from four centersChin J Cancer201433315916423958058
   PubMedGoogle Scholar
• JiRCHypoxia and lymphangiogenesis in tumor microenvironment and metastasisCancer Lett2014346161624333723
   PubMed Web of Science ®Google Scholar
• RavalRRLauKWTranMGContrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinomaMol Cell Biol200525135675568615964822
   PubMed Web of Science ®Google Scholar
• RankinEBGiacciaAJThe role of hypoxia-inducible factors in tumorigenesisCell Death Differ200815467868518259193
   PubMed Web of Science ®Google Scholar
• HuYLiuJHuangHRecent agents targeting HIF-1alpha for cancer therapyJ Cell Biochem2013114349850922961911
   PubMed Web of Science ®Google Scholar
• HuiEPChanATPezzellaFCoexpression of hypoxia-inducible factors 1 alpha and 2 alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survivalClin Cancer Res2002882595260412171890
   PubMedGoogle Scholar
• WanXBFanXJHuangPYAurora-A activation, correlated with hypoxia-inducible factor-1 alpha, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinomaCancer Sci201210381586159422587416
   PubMedGoogle Scholar
• XueguanLXiaoshenWYongshengZChaosuHChunyingSYanFHypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamideClin Oncol (R Coll Radiol)200820860661218692368
   PubMedGoogle Scholar
• TokatlianTSeguraTsiRNA applications in nanomedicineWiley Interdiscip Rev Nanomed Nanobiotechnol20102330531520135697
   PubMed Web of Science ®Google Scholar
• VarkouhiAKVerheulRJSchiffelersRMLammersTStormGHenninkWEGene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosanBioconjug Chem201021122339234621049986
   PubMedGoogle Scholar
• OfekPFischerWCalderonMHaagRSatchi-FainaroRIn vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriersFASEB J20102493122313420385622
   PubMedGoogle Scholar
• SuW-PChengF-YShiehD-BYehC-SSuW-CPLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cellsInt J Nanomedicine201274269428322904633
   PubMed Web of Science ®Google Scholar
• TamuraANagasakiYSmart siRNA delivery systems based on polymeric nanoassemblies and nanoparticlesNanomedicine2010571089110220874023
   PubMedGoogle Scholar
• ZhouJWuJHafdiNBehrJ-PErbacherPPengLPAMAM dendrimers for efficient siRNA delivery and potent gene silencingChem Commun20062223622364
   PubMed Web of Science ®Google Scholar
• GeusensBLambertJDe SmedtSCBuyensKSandersNNVan GeleMUltradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytesJ Control Release2009133321422018973779
   PubMed Web of Science ®Google Scholar
• ParkTGJeongJHKimSWCurrent status of polymeric gene delivery systemsAdv Drug Deliv Rev200658446748616781003
   PubMed Web of Science ®Google Scholar
• SonSKimWJBiodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA deliveryBiomaterials201031113314319783041
   PubMedGoogle Scholar
• BlumJSSaltzmanWMHigh loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysineJ Control Release20081291667218511145
   PubMedGoogle Scholar
• DavisMEZuckermanJEChoiCHEvidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature20104647291U1067U1140
   PubMed Web of Science ®Google Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov20109861562720616808
   PubMed Web of Science ®Google Scholar
• WoodrowKACuYBoothCJSaucier-SawyerJKWoodMJSaltzmanWMIntravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNANat Mater20098652653319404239
   PubMed Web of Science ®Google Scholar
• HuangLChenHZhengYNanoformulation of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapyIntegr Biol20113109931002
   Google Scholar
• MaYZhengYLiuKNanoparticles of poly(lactide-co-glycolide)-d-a-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatmentNanoscale Res Lett2010571161116920596457
   PubMed Web of Science ®Google Scholar
• CollnotEMBaldesCWempeMFMechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: Influence on ATPase activity and membrane fluidityMol Pharm20074346547417367162
   PubMed Web of Science ®Google Scholar
• ZhangZMeiLFengS-SVitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-based nanomedicineNanomedicine20127111645164723210711
   PubMed Web of Science ®Google Scholar
• ConstantinouCPapasAConstantinouAIVitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogsInt J Cancer2008123473975218512238
   PubMed Web of Science ®Google Scholar
• NeuzilJTomasettiMZhaoYVitamin E analogs, a novel group of “mitocans,” as anticancer agents: The importance of being redox-silentMol Pharmacol20077151185119917220355
   PubMed Web of Science ®Google Scholar
• YoukHJLeeEChoiMKEnhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycolJ Controll Release200510714352
   PubMed Web of Science ®Google Scholar
• QiuBJiMSongXCo-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancerNanoscale Res Lett2012766623216701
   PubMed Web of Science ®Google Scholar
• ZhengYChenHZengXSurface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapyNanoscale Res Lett2013816123570619
   PubMed Web of Science ®Google Scholar
• KungALWangSKlcoJMKaelinWGLivingstonDMSuppression of tumor growth through disruption of hypoxia-inducible transcriptionNat Med20006121335134011100117
   PubMed Web of Science ®Google Scholar
• StoeltzingOMcCartyMFWeyJSRole of hypoxia-inducible factor 1 alpha in gastric cancer cell growth, angiogenesis, and vessel maturationJ Natl Cancer Inst2004961294695615199114
   PubMedGoogle Scholar
• ZhangXKonTWangHEnhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1 alphaCancer Res200464228139814215548675
   PubMedGoogle Scholar
• BartholomeuszGCherukuriPKingstonJIn vivo therapeutic silencing of hypoxia-inducible factor 1 alpha (HIF-1 alpha) using single-walled carbon nanotubes noncovalently coated with siRNANano Res20092427929120052401
   PubMed Web of Science ®Google Scholar
• FattalEBochotaAState of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriersInt J Pharm2008364223724818619528
   PubMed Web of Science ®Google Scholar
• CunDJensenDKMaltesenMJHigh loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterizationEur J Pharm Biopharm2011771263521093589
   PubMed Web of Science ®Google Scholar
• TaharaKSakaiTYamamotoHTakeuchiHKawashimaYEstablishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene deliveryInt J Pharm20083541–221021618178349
   PubMed Web of Science ®Google Scholar
• ZhaoSTanSGuoYpH-Sensitive docetaxel-loaded D-alpha-tocopheryl polyethylene glycol succinate-poly(beta-amino ester) copolymer nanoparticles for overcoming multidrug resistanceBiomac-romolecules201314826362646
   PubMed Web of Science ®Google Scholar
• GerberHPMcMurtreyAKowalskiJVascular endothelial growth factor regulates endothelial cell survival through the phosphati-dylinositol 3′-kinase Akt signal transduction pathway – requirement for Flk-1/KDR activationJ Biol Chem19982734630336303439804796
   PubMed Web of Science ®Google Scholar
• ErlerJTCawthorneCJWilliamsKJHypoxia-mediated down-regulation of bid and bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistanceMol Cell Biol20042472875288915024076
   PubMed Web of Science ®Google Scholar
• UnruhAResselAMohamedHGThe hypoxia-inducible factor-1 alpha is a negative factor for tumor therapyOncogene200322213213322012761491
   PubMed Web of Science ®Google Scholar
• AkakuraNKobayashiMHoriuchiIConstitutive expression of hypoxia-inducible factor-1 alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivationCancer Res200161176548655411522653
   PubMed Web of Science ®Google Scholar